University of Missouri, ENT and Allergy Center of Missouri
Columbia, Missouri, United States
Otolaryngologist in Columbia, Missouri
812 N Keene St, Columbia, MO 65201
About University of Missouri, ENT and Allergy Center of Missouri
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at University of Missouri, ENT and Allergy Center of Missouri
During the past decade, University of Missouri, ENT and Allergy Center of Missouri conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
2015-11-01
2021-06-21
Completed
2,425
Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes
2017-01-24
2018-10-09
Completed
607
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at University of Missouri, ENT and Allergy Center of Missouri
According to Clinical.Site data, the most researched conditions in "University of Missouri, ENT and Allergy Center of Missouri" are
"Chronic Rhinosinusitis" (1 trials), "Nasal Polyps" (1 trials) and "Refractory Chronic Cough" (1 trials). Many other conditions were trialed in "University of Missouri, ENT and Allergy Center of Missouri" in a lesser frequency.
Clinical Trials Intervention Types at University of Missouri, ENT and Allergy Center of Missouri
Most popular intervention types in "University of Missouri, ENT and Allergy Center of Missouri" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "BLU-5937" (1 trials) and "Omalizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of Missouri, ENT and Allergy Center of Missouri
The vast majority of trials in "University of Missouri, ENT and Allergy Center of Missouri" are
2 trials for "All" genders.
Clinical Trials Status at University of Missouri, ENT and Allergy Center of Missouri
Currently, there are NaN active trials in "University of Missouri, ENT and Allergy Center of Missouri".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in University of Missouri, ENT and Allergy Center of Missouri,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University of Missouri, ENT and Allergy Center of Missouri, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".